Join us for an informative course designed to thoroughly explore the pathological diagnosis and clinical implications of various breast lesions found in surgical specimens and core needle biopsies. This course places a strong emphasis on the latest adjunctive immunohistochemical and molecular techniques that aid in diagnosing and categorizing both benign and malignant breast lesions, as well as guiding patient care. Through a blend of engaging lectures, interactive microscopy sessions, and panel Q&A discussions, participants will gain valuable insights into this dynamic field.
Key Learning Objectives:
Comprehensive Knowledge: Acquire a deep understanding of the diagnostic criteria and clinical significance associated with a diverse range of benign, in situ, and malignant breast lesions commonly encountered in surgical specimens and core needle biopsies.
Expert Differential Diagnosis: Engage in insightful discussions surrounding common diagnostic challenges in breast pathology. Grasp the potential and limitations of supplementary immunohistochemical and molecular tests in achieving precise diagnoses.
Proficiency in Patient Management: Explore prognostic and predictive assays relevant to individuals with breast cancer. Develop the skills needed to interpret these assays effectively, playing a pivotal role in shaping treatment strategies.
Why Attend:
This educational course is an essential platform for clinicians, pathologists, and researchers aiming to expand their knowledge of contemporary breast pathology issues. By integrating cutting-edge insights and practical methodologies, participants will be equipped to address diagnostic uncertainties and provide optimal patient care.
Course Topics Include:
Exploring Lobular, Mucinous, and Fibroepithelial Lesions – Led by Laura C. Collins, MD
Understanding Lumpectomy Margin Evaluation, Lesions, and Salivary Gland-like Tumors of the Breast – Presented by Stuart J. Schnitt, MD
Unpacking Papillary Lesions, Spindle Cell Lesions, and Uncommon Breast Cancers – Guided by Kimberly H. Allison, MD
Navigating Neoadjuvant Chemotherapy, Vascular Lesions, and Intraductal Proliferative Lesions – Expertise shared by Gregory R. Bean, MD, PhD
Decoding Ductal, Nipple, Inflammatory, and Reactive Lesions – Presented by Edi Brogi, MD, PhD
Analyzing Small Glandular Proliferations, Fibroepithelial Lesions, and ER, PR, and HER2 Testing – Presented by Ashley M. Cimino-Mathews, MD
Delving into Hot and Controversial Topics in Breast Pathology
Engaging in Panel Discussions for Q&A
Original Release Date: July 8, 2023
Don’t miss this opportunity to enrich your knowledge and contribute to the advancement of breast pathology. Register now to secure your spot in this insightful course.
